33 studies found for:    " November 01, 2008":" December 01, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine Trials
Conditions: HIV Infection;   HIV Seronegativity
Intervention:
2 Recruiting An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children
Condition: Human Immunodeficiency Virus (HIV)
Intervention: Drug: Maraviroc
3 Completed Directly Observed Therapy for Community-Released HIV+ Prisoners
Conditions: HIV/AIDS;   Substance Abuse
Intervention: Behavioral: Directly administered antiretroviral therapy
4 Unknown  Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus
Conditions: Dry Eye Syndromes;   HIV Seropositivity
Interventions: Drug: cyclosporine and sodium carboximethycellulose;   Drug: sodium carboximethycellulose
5 Active, not recruiting A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Efficacy of TMC278 in Human Immunodeficiency Virus Infected Adolescents
Condition: Human Immuno Deficiency (HIV) Infections
Interventions: Drug: TMC278;   Drug: Zidovudine;   Drug: Abacavir;   Drug: Tenofovir disoproxil fumarate;   Drug: Lamivudine;   Drug: Emtricitabine
6 Enrolling by invitation Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection
Conditions: HIV Infections;   AIDS;   Opportunistic Infections
Intervention:
7 Completed A Trial to Determine the Long-term Durability of Virologic Suppression in Kaletra Recipients With Imperfect Adherence
Condition: HIV Infection
Intervention: Other: MEMS cap monitoring
8 Completed Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial
Conditions: Cardiovascular Risk;   HIV Infection
Interventions: Dietary Supplement: Lovaza;   Dietary Supplement: sugar pill
9 Completed Cognitive Behavioral Treatment to Reduce Alcohol Use Among HIV-Infected Kenyans
Conditions: Binge Drinking;   Alcohol Abuse;   Alcohol Dependence;   HIV Infections
Interventions: Behavioral: HIV support group;   Behavioral: CBT
10 Unknown  Integrase Resistance Analysis in HIV Patients Who Interrupted Raltegravir Due to Incomplete Viral Suppression
Condition: HIV Infection
Intervention: Drug: resume raltegravir
11 Unknown  Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia
Conditions: HIV Infection;   Hemophilia A
Intervention:
12 Active, not recruiting Micronutrients and Antioxidants in HIV Infection
Condition: HIV Infection
Interventions: Dietary Supplement: Micronutrients and antioxidants;   Dietary Supplement: Multivitamins and minerals
13 Completed Efficacy And Security Of Annual And Biennial Zoledronic Acid For Osteoporosis Treatment In An HIV-Infected Patients' Cohort
Condition: HIV Infections
Interventions: Drug: Zoledronic acid;   Behavioral: Lifestyle modifications
14 Completed Healthy Teen Girls: HIV Risk Reduction
Condition: HIV-infection/Aids
Intervention: Behavioral: Cognitive-behavioral HIV/STD risk reduction
15 Recruiting Antiretroviral Therapy for Acute HIV Infection
Condition: Acute HIV Infection
Intervention: Drug: Anti-HIV Agents
16 Completed A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults
Conditions: Human Immunodeficiency Virus;   Human Papillomavirus- 6, 11, 16, 18;   Adolescent;   Papillomavirus Vaccines
Interventions: Drug: GARDASIL (Quadrivalent HPV (Types 6,11, 16, 18);   Biological: Administration of 3 doses of quaddrivalent;   Behavioral: Administration of an on line web-based risk
17 Completed A Safety Study of Two Dapivirine (TMC120) Vaginal Gels in the United States
Condition: HIV-1 Infections
Interventions: Drug: dapivirine;   Drug: placebo
18 Completed A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL
Conditions: Lymphoma, AIDS Related;   HIV Infections
Intervention: Drug: R-EPOCH and cART
19 Terminated Immune Responses in Patients Treated With Raltegravir
Condition: HIV Infections
Intervention: Biological: Various vaccines
20 Recruiting Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population
Condition: Acute HIV Infection
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results
Indicates status has not been verified in more than two years